A carregar...

Statin Drugs, Metabolic Pathways, and Asthma: A Therapeutic Opportunity Needing Further Research

The chance discovery of hydroxymethylglutaryl (HMG)-CoA reductase inhibitors has revolutionized the care of patients with cardiovascular disease. The unexpected finding that these cholesterol-lowering drugs (or ‘statins’) also posses pleiotropic immunomodulatory properties, has opened a new area of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Metab Lett
Main Authors: Zeki, Amir A., Kenyon, Nicholas J., Goldkorn, Tzipora
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6082624/
https://ncbi.nlm.nih.gov/pubmed/21198438
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!